News Conference News ACC 2023 Mountains of Cath Lab Waste Could Be Recycled, Study Estimates Todd Neale March 01, 2023
News Conference News CRT 2023 Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months Yael L. Maxwell February 28, 2023
News Conference News ACC 2023 Too Many HF Patients Exiting Rural Hospitals Miss Out on Endorsed Therapies Caitlin E. Cox February 23, 2023
News Conference News STS 2023 Surgeons ‘Implore’ Colleagues to Learn TEER Lest They Become ‘Dinosaurs’ Yael L. Maxwell February 02, 2023
News Conference News STS 2023 Large Medicare Analysis Reopens Debate Over Multivessel Revascularization Yael L. Maxwell January 24, 2023
News Conference News Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices L.A. McKeown November 18, 2022
News Conference News AHA 2022 Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI Yael L. Maxwell November 10, 2022
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News AHA 2022 PRECISE CT-Based Strategy Allows Clinicians to ‘Do Less’ for Stable Chest Pain Yael L. Maxwell November 06, 2022
News Conference News VIVA 2022 ‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups L.A. McKeown November 04, 2022
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Conference News TCT 2022 Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year L.A. McKeown September 23, 2022
News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022
News Conference News TCT 2022 Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances Caitlin E. Cox September 19, 2022
News Conference News TCT 2022 Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL Yael L. Maxwell September 19, 2022
News Conference News TCT 2022 SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss Michael O'Riordan September 19, 2022
News Conference News TCT 2022 Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes Todd Neale September 18, 2022
News Conference News TCT 2022 FLASH: More Data to Support Mechanical Thrombectomy in PE L.A. McKeown September 18, 2022
News Conference News TCT 2022 TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR Yael L. Maxwell September 17, 2022